Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.24B
-
Number of holders
-
1170
-
Total 13F shares, excl. options
-
1.4B
-
Shares change
-
-9.95M
-
Total reported value, excl. options
-
$99.3B
-
Value change
-
-$716M
-
Put/Call ratio
-
1.91
-
Number of buys
-
639
-
Number of sells
-
-460
-
Price
-
$70.86
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q1 2014
1,303 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q1 2014.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.4B shares
.
Largest 10 shareholders include Capital Research Global Investors (123M shares), FMR LLC (105M shares), VANGUARD GROUP INC (77.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (73.9M shares), State Street Corp (61.1M shares), Capital World Investors (40.9M shares), BlackRock Institutional Trust Company, N.A. (40.4M shares), Invesco Ltd. (31.2M shares), WELLINGTON MANAGEMENT CO LLP (30.3M shares), and JPMORGAN CHASE & CO (22.5M shares).
This table shows the top 1170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.